Lantheus
LNTH
Collegium Pharmaceutical
COLL
星座品牌
STZ
奧洛茲美醫療
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
(Q1)2024/12/31 | (FY)2024/09/30 | (Q4)2024/09/30 | (Q3)2024/06/30 | (Q2)2024/03/31 | (Q1)2023/12/31 | (FY)2023/09/30 | (Q4)2023/09/30 | (Q3)2023/06/30 | (Q2)2023/03/31 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | 25.15%5,135.4萬 | -1.75%1.83億 | 28.53%5,330.3萬 | 9.79%4,672.4萬 | -7.18%4,212.2萬 | -28.06%4,103.5萬 | -41.16%1.86億 | -43.74%4,147萬 | -46.12%4,255.7萬 | -43.87%4,537.8萬 |
營業收入 | 25.15%5,135.4萬 | -1.75%1.83億 | 28.53%5,330.3萬 | 9.79%4,672.4萬 | -7.18%4,212.2萬 | -28.06%4,103.5萬 | -41.16%1.86億 | -43.74%4,147萬 | -46.12%4,255.7萬 | -43.87%4,537.8萬 |
主營業務成本 | 34.67%3,621.2萬 | -4.57%1.25億 | 35.04%3,797.8萬 | 9.46%3,163.3萬 | -10.53%2,829.9萬 | -36.17%2,689萬 | -47.83%1.31億 | -50.38%2,812.3萬 | -53.25%2,889.8萬 | -50.84%3,162.9萬 |
毛利 | 7.05%1,514.2萬 | 4.87%5,838.4萬 | 14.82%1,532.5萬 | 10.48%1,509.1萬 | 0.54%1,382.3萬 | -5.18%1,414.5萬 | -15.90%5,567.2萬 | -21.64%1,334.7萬 | -20.43%1,365.9萬 | -16.72%1,374.9萬 |
營業費用 | 6.01%1,393.3萬 | 2.93%5,462.6萬 | 8.38%1,432.7萬 | 3.27%1,391.3萬 | 3.10%1,324.3萬 | -2.91%1,314.3萬 | -6.40%5,307.3萬 | -14.69%1,321.9萬 | -3.73%1,347.2萬 | -10.56%1,284.5萬 |
銷售和管理費用 | 5.45%1,329.2萬 | 2.65%5,232.7萬 | 7.46%1,366.3萬 | 3.17%1,335.8萬 | 3.24%1,270.1萬 | -3.12%1,260.5萬 | -6.85%5,097.5萬 | -15.27%1,271.4萬 | -4.12%1,294.8萬 | -11.34%1,230.2萬 |
折舊攤銷及損耗 | 19.14%64.1萬 | 9.58%229.9萬 | 31.49%66.4萬 | 5.92%55.5萬 | -0.18%54.2萬 | 2.28%53.8萬 | 6.17%209.8萬 | 2.85%50.5萬 | 7.16%52.4萬 | 11.50%54.3萬 |
-折舊及攤銷 | 19.14%64.1萬 | 9.58%229.9萬 | 31.49%66.4萬 | 5.92%55.5萬 | -0.18%54.2萬 | 2.28%53.8萬 | 6.17%209.8萬 | 2.85%50.5萬 | 7.16%52.4萬 | 11.50%54.3萬 |
營業利潤 | 20.66%120.9萬 | 44.59%375.8萬 | 679.69%99.8萬 | 529.95%117.8萬 | -35.84%58萬 | -27.39%100.2萬 | -72.64%259.9萬 | -91.68%12.8萬 | -94.10%18.7萬 | -57.89%90.4萬 |
淨非營業利息收入(費用) | -27.10%-66.6萬 | -16.02%-231.8萬 | -25.48%-65.5萬 | -11.55%-58.9萬 | -16.03%-55萬 | -10.55%-52.4萬 | -56.58%-199.8萬 | -21.68%-52.2萬 | -76.59%-52.8萬 | -76.21%-47.4萬 |
利息費用 | 27.10%66.6萬 | 16.02%231.8萬 | 25.48%65.5萬 | 11.55%58.9萬 | 16.03%55萬 | 10.55%52.4萬 | 56.58%199.8萬 | 21.68%52.2萬 | 76.59%52.8萬 | 76.21%47.4萬 |
其他淨收入(費用) | 3,240.00%31.4萬 | -355.26%-34.6萬 | -95.02%3.5萬 | -62.45%-43.7萬 | 159.46%6.6萬 | 97.49%-1萬 | 99.07%-7.6萬 | 70.3萬 | -26.9萬 | -11.1萬 |
出售證券收益 | ---- | ---- | ---- | -62.45%-43.7萬 | ---- | ---- | ---- | ---- | ---26.9萬 | ---- |
其他非經營收入(費用) | 3,240.00%31.4萬 | -355.26%-34.6萬 | ---- | ---- | 159.46%6.6萬 | 97.49%-1萬 | -118.49%-7.6萬 | ---- | ---- | ---11.1萬 |
稅前利潤 | 83.12%85.7萬 | 108.38%109.4萬 | 22.33%37.8萬 | 124.92%15.2萬 | -69.91%9.6萬 | -7.69%46.8萬 | 909.62%52.5萬 | 104.38%30.9萬 | -121.24%-61萬 | -83.01%31.9萬 |
所得稅 | 3.13%19.8萬 | 374.24%54.3萬 | 149.25%13.1萬 | 290.56%34.3萬 | -221.78%-12.3萬 | 30.61%19.2萬 | -109.04%-19.8萬 | -235.71%-26.6萬 | -125.21%-18萬 | -83.31%10.1萬 |
除稅後利潤 | 138.77%65.9萬 | -23.79%55.1萬 | -57.04%24.7萬 | 55.58%-19.1萬 | 0.46%21.9萬 | -23.33%27.6萬 | 133.82%72.3萬 | 107.92%57.5萬 | -119.93%-43萬 | -82.88%21.8萬 |
持續經營利潤 | 138.77%65.9萬 | -23.79%55.1萬 | -57.04%24.7萬 | 55.58%-19.1萬 | 0.46%21.9萬 | -23.33%27.6萬 | 133.82%72.3萬 | 107.92%57.5萬 | -119.93%-43萬 | -82.88%21.8萬 |
歸屬於少數股東的淨利潤 | 24.3萬 | 0 | ||||||||
歸屬於母公司的淨利潤 | 50.72%41.6萬 | -23.79%55.1萬 | -57.04%24.7萬 | 55.58%-19.1萬 | 0.46%21.9萬 | -23.33%27.6萬 | 128.44%72.3萬 | 107.57%57.5萬 | -119.93%-43萬 | -82.01%21.8萬 |
優先股派息 | 19.44%8.6萬 | 15.49%32.8萬 | 19.44%8.6萬 | 21.43%8.5萬 | 21.43%8.5萬 | 0.00%7.2萬 | -51.54%28.4萬 | 1.41%7.2萬 | -1.41%7萬 | -69.96%7萬 |
其他優先股派息 | ||||||||||
歸屬於普通股股東的淨利潤 | 61.76%33萬 | -49.20%22.3萬 | -67.99%16.1萬 | 44.80%-27.6萬 | -9.46%13.4萬 | -29.17%20.4萬 | 114.03%43.9萬 | 106.56%50.3萬 | -123.96%-50萬 | -84.88%14.8萬 |
基本每股收益 | 70.59%0.29 | -48.65%0.19 | -66.67%0.14 | 45.24%-0.23 | -8.33%0.11 | -29.17%0.17 | 112.21%0.37 | 105.53%0.42 | -121.32%-0.42 | -88.00%0.12 |
稀釋每股收益 | 64.71%0.28 | -50.00%0.18 | -68.29%0.13 | 45.24%-0.23 | -8.33%0.11 | -29.17%0.17 | 111.88%0.36 | 105.40%0.41 | -122.46%-0.42 | -87.37%0.12 |
每股派息 | ||||||||||
貨幣單位 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
會計準則 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
審計意見 | -- | 無保留意見 | -- | -- | -- | -- | 無保留意見 | -- | -- | -- |